Reyedar’s mission is to democratise access to early diagnosis of life-impairing degenerative diseases. By combining state-of-the-art infra-red eye-tracking powered by Deep Learning, they create accessible medical devices for diagnosing visual impairments, neurological diseases, and cognitive disorders in just a few minutes of non-invasive testing. This unique hardware-software combination is called SONDA (Standardized Oculomotor and Neuro-ophthalmic Disorders Assessment).
SONDA allows for extremely fast, objective, and patient-friendly quantification of eye movement properties and their conversion into a novel diagnostic biomarker. Their first product, SONDA SCREENER, improves the diagnostic workflow of Glaucoma and other severe retinopathies by enabling unprecedentedly fast and simple functional vision testing inside and outside hospitals.